Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A neuroblastic tumor characterized by the presence of a ganglioneuroblastoma component and the formation of Schwannian stroma which constitutes more than fifty-percent of the tumor volume.
No clinical trials have been registered for schwannian stroma-rich and stroma-poor composite ganglioneuroblastoma.
1 publication has been identified in PubMed for schwannian stroma-rich and stroma-poor composite ganglioneuroblastoma. Research spans Case Report / Case Series (100%).
Cardona JJ (2025). [PMID: 40127476](https://pubmed.ncbi.nlm.nih.gov/40127476/). *Journal of neurosurgery. Case lessons*. [Case Report / Case Series]
Data assembled from 2 of 12 sources · Last updated Sep 20, 2026, 9:35 PM UTC